Skip to content
Search

Latest Stories

Hub and spoke - Why Independents Need It Now

By Mike Hewitson

Independent community pharmacy owners and staff have been under relentless pressure for the last 18 months. With prescription volumes strong, despite the growth of online pharmacies it is easy to feel overwhelmed by the number of things that need to be done.


If your staff are anything like mine, they have been incredible, but we do not want to burn them out either.

In 2021, independents were called upon to take part in the roll-out of the Covid vaccination programme, but many were not able to grasp the opportunity because they found it impossible to get on top of the day-to-day dispensing workload.

Some still are.

It has been a brilliant example of why we urgently need to bring forward centralised hub and spoke dispensing for independent community pharmacy.

The necessary primary legislation achieved Royal Assent back in February and we’re now in the midst of industry and public consultations. This consultation will be essential in determining how the regulations should be updated so that independents can use this technology.

If I had hub and spoke dispensing switched on right now, I would not be worried about burning my staff out, because I could take a lot of the mundane pressure off their shoulders. This would allow them to focus their time and energy on the patients with the greatest needs.

With the launch of the Discharge Medication Review service in February, pharmacies must now think about how they handle patients after they are discharged from hospital, to help them get the most from their medicines and avoid unnecessary re-admissions.

This is an important integration with the work of the Primary Care Networks, demonstrating the value of the relationships that community pharmacy teams have with their patients. More immediately, with hub and spoke dispensing I could plan our Covid vaccination service more easily because I would know that the day-to-day work was being done reliably, efficiently, and safely.

Like many others, I am eager to get on with a fully automated, independent future with more of our income coming from clinical services. While online providers can dispense a prescription, they find it more difficult to give the face-to-face clinical care that many patients want and need.

This is how independents will secure their future, and soon hub and spoke dispensing will be there to help me make it happen.

Mike Hewitson owns the Beaminster Pharmacy in Dorset and is a non-executive director of HubRx

More For You

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less